|
|
|
Volumn 61, Issue 129, 2014, Pages 99-104
|
|
Phase I trial of preoperative chemoradiation therapy with S-1 for low rectal cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
OTERACIL;
S 1 (COMBINATION);
TEGAFUR;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
CANCER GRADING;
CANCER STAGING;
CHEMORADIOTHERAPY;
DRUG COMBINATION;
HUMAN;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
RADIATION DOSE FRACTIONATION;
RECTUM TUMOR;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
CHEMORADIOTHERAPY;
COMBINED MODALITY THERAPY;
DOSE FRACTIONATION;
DRUG COMBINATIONS;
HUMANS;
MIDDLE AGED;
NEOPLASM GRADING;
NEOPLASM STAGING;
OXONIC ACID;
RECTAL NEOPLASMS;
TEGAFUR;
TREATMENT OUTCOME;
|
|
EID: 84902686726
PISSN: 01726390
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
